AFLAC Inc., US0010551028

AFLAC Inc. stock holds firm as Japan Post trims stake and Q2 2026 results miss EPS consensus

Published on 09/04/2026 at 19:17 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

AFLAC Inc. stock is trading near USD 118 as of early September 2026, with insider selling by major shareholder Japan Post Holdings and mixed second quarter 2026 results providing a nuanced backdrop for investors.

Isometrische Grafik: Versicherungsantrag, Prüfung und Auszahlung
AFLAC Inc. isometric 3D insurance claim process application review payout ISIN US0010551028, Illustration mit AI erstellt.

AFLAC Inc. (US0010551028) stock traded at around USD 118.32 on September 4, 2026, keeping the supplemental-insurance specialist close to recent highs despite fresh insider selling and a slight earnings miss in the latest quarter, according to MarketBeat data.

Insider selling by Japan Post and institutional flows

Recent filings show that Japan Post Holdings Co., Ltd., a 10 percent owner and director of AFLAC Inc., has continued to reduce its stake. According to an insider-trading report compiled by Investing.com, Japan Post sold 13,500 AFLAC shares on September 2, 2026, for a total of USD 1,582,065 at prices between USD 116.67 and USD 117.50 per share, implying a weighted average sale price of USD 117.19.

The same data set indicates that AFLAC shares were trading at about USD 117.88 in early September 2026, corresponding to a price-earnings ratio of 12.66 and a notably low PEG ratio of 0.11. This valuation profile suggests that the market prices AFLAC stock at a discount to its long-term earnings growth metrics, even as separate analyses point to a fair value below the current share price.

Mixed second quarter 2026 earnings picture

For the second quarter of 2026, AFLAC Inc. reported a mixed set of financial results. According to coverage of the earnings release cited by Investing.com, adjusted earnings per share came in at USD 1.75 for Q2 2026, slightly below the analyst consensus expectation of USD 1.78. In contrast, revenue for the same quarter reached USD 4.12 billion, edging above the market forecast of USD 4.11 billion and highlighting solid top-line momentum.

This combination of a modest earnings-per-share shortfall and a small revenue beat gives investors a nuanced picture: profitability metrics lag consensus by USD 0.03 per share, while reported revenue exceeds expectations by about USD 0.01 billion in Q2 2026. The divergence suggests that factors such as claims experience, investment income or expenses weighed on margins even as sales and premium growth remained slightly ahead of projections.

Analyst sentiment and conference spotlight

Analyst sentiment around AFLAC stock appears balanced yet cautious. Data aggregated by MarketBeat indicates that AFLAC carries a consensus rating of Hold and an average price target of USD 116.62, with individual targets spanning a range from USD 99 to USD 138. This implies that the current trading level near USD 118 sits modestly above the consensus target, but remains within the published range of analyst expectations.

In parallel with the earnings release, Wolfe Research has initiated coverage of AFLAC with a recommendation of Underperform and a price target of USD 103.00, according to recent Investing.com reporting. Compared with the early-September trading region around USD 117.88, the Wolfe Research target implies potential downside of approximately USD 14.88 per share, a signal of skepticism about upside in the near term despite the company’s strong franchise and capital position.

Price performance and technical context

MarketBeat figures show that shares of AFLAC opened at USD 118.32 on September 4, 2026, aligning closely with the USD 117.88 trading level reported by multiple Investing.com snapshots for early September 2026. The narrow band between these prices underscores the stock’s recent stability after a period in which the one-month share price return declined by 5.43 percent, as noted in an analysis by Simply Wall St.

Longer-term performance indicators remain robust. Simply Wall St data points to a one-year total shareholder return of 11.32 percent and a five-year total shareholder return of 140.36 percent for AFLAC stock, illustrating that investors who have held the shares over extended horizons have been rewarded by a combination of price appreciation and dividend income.

Dividend stream and shareholder returns

The insurance provider continues to return cash to shareholders through dividends. Recent coverage of AFLAC’s payout policy indicates that the company paid a quarterly dividend of USD 0.61 per share, distributed on September 1, with shareholders of record as of August 19 and an ex-dividend date also on August 19. At a share price around USD 117.88, this quarterly dividend corresponds to an annualized dividend of USD 2.44 per share, which implies a dividend yield in the neighborhood of about 2.1 percent.

For investors, the combination of a mid-single-digit dividend yield and solid long-term total returns makes AFLAC stock a candidate for income-oriented portfolios, even if current valuation metrics and analyst targets suggest limited upside from present levels.

Representative product: supplemental cancer insurance

AFLAC Inc. is widely recognized for its supplemental insurance offerings that complement primary health and life coverage, with cancer insurance representing a flagship product category in its portfolio. These policies typically provide lump-sum or periodic benefits to policyholders diagnosed with covered cancers, designed to help bridge gaps in traditional medical insurance and to cover out-of-pocket expenses such as travel, lost income or specialized treatment.

While detailed product-level revenue breakdowns for Q2 2026 are not included in the available summaries, AFLAC’s long-standing focus on cancer and supplemental health insurance remains central to its brand positioning and to ongoing demand trends, particularly in the United States and Japan where the company has deep distribution relationships.

Stock valuation and investor perspective

As of September 4, 2026, AFLAC stock trading around USD 118.32 places the shares modestly above the consensus price target of USD 116.62 and well above the USD 103.00 target announced by Wolfe Research. The early-September price region also aligns closely with recent MarketBeat and Investing.com data showing levels near USD 117.88, underpinned by a price-earnings ratio of 12.66 and a low PEG ratio of 0.11.

For investors, this backdrop means that AFLAC stock currently offers a blend of income, moderate valuation and strong historical performance, offset by ongoing insider selling from a major shareholder and an earnings profile that recently undershot consensus by USD 0.03 per share in Q2 2026.

Disclaimer...

en | US0010551028 | AFLAC INC. | boerse | 70055905 | bgmi